The work is focused in the following four main areas: 1.) reagent repository, 2.) pharmacology and toxicology resources, 3.) clinical trial and pharmacology study specimen archiving under good…

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N92019D00018
Awardee
Awarding agency
Task orders
10 $6,975,731 obligated

Award facts

Opportunity
Combined order value
$6,975,731 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 87% used
$8,000,000.00
Maximum order
$8,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Heart Lung and Blood Institute (NHLBI), a civilian agency, awarded a single-award Indefinite Delivery Contract (IDC) valued up to $8,000,000 to the Trustees of Indiana University, doing business as Indiana University Indianapolis, to operate the National Gene Vector Biorepository and Coordinating Center (NGVB). The work under this IDC is focused on four main areas: 1) a reagent repository, 2) pharmacology and toxicology resources, 3) archiving of clinical trial and pharmacology study specimens under Good Laboratory Practices (GLP), and 4) research and development of qualified assays for insertional site analysis.

This IDC includes multiple firm fixed-price and cost-no-fee delivery orders issued to Indiana University Indianapolis, valued between $176,690.94 and $3,453,442.91, with performance periods through 2026. The delivery orders support core administrative activities, core laboratory operations, and scientific activities for the NGVB program, which aims to enhance gene therapy research by providing specialized services not typically available at most institutions. Indiana University Indianapolis, a prominent research university, has demonstrated extensive capabilities in supporting federal agencies through research, clinical trials, and specialized service contracts.

Description

As the agency reported it.

The work is focused in the following four main areas: 1.) reagent repository, 2.) pharmacology and toxicology resources, 3.) clinical trial and pharmacology study specimen archiving under good laboratory practices (GLP) conditions, and 4.) research and development of qualified assays for insertional site analysis. The ngvb will also maintain an up-to-date website that describes the resources available to researchers and has interactive tools such as those available at the current website: https://ngvbcc.ORG/home.action.

Task orders

Task order Ordering agency Obligated Awarded
[25-010983] gene assays, including RCL and RCR, including qpcrbased methods and culturebased RCL and RCR testing, for… 75N92025F00002 National Heart Lung and Blood Institute (NIH) $250,000
[25-010983] gene assays, including RCL and RCR, including qpcrbased methods and culturebased RCL and RCR testing, for… 75N92025F00001 National Heart Lung and Blood Institute (NIH) $250,000
National gene vector biorepository and coordinating center (ngvb), task area b - core laboratory activities 75N92024F00002 National Heart Lung and Blood Institute (NIH) $651,981
National gene vector biorepository and coordinating center (ngvb): task area b - scientific activities 75N92024F00001 National Heart Lung and Blood Institute (NIH) $873,557
National gene vector biorepository and coordinating center (ngvb): task area b - scientific activities 75N92023F00001 National Heart Lung and Blood Institute (NIH) $248,606
Task area b: core laboratory activities for nhlbi for the period 5/20/2022 - 5/19/2023 75N92022F00001 National Heart Lung and Blood Institute (NIH) $176,691
National gene vector biorepository and coordinating center (ngvb): task area b, core scientific activities for nhlbi 75N92020F00001 National Heart Lung and Blood Institute (NIH) $358,200
National gene vector biorepository and coordinating center (ngvb): task area b, core scientific activities for NCI 75N92020F00002 National Heart Lung and Blood Institute (NIH) $310,198
Purpose of the ngvb contract is to continue supporting gene therapy research. 75N92019F00074 National Heart Lung and Blood Institute (NIH) $403,055
Line item 1: task area a- core administrative activities 75N92019F00068 National Heart Lung and Blood Institute (NIH) $3,453,443

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 · National gene vector biorepository and coordinating center (ngvb) $0
Supplemental Agreement for work within scope P00001 · National gene vector biorepository and coordinating center (ngvb). The work is focused in the following four main areas: 1.) reagent repository, 2.)… $0
Original award $0

Quick answers

Who was awarded contract 75N92019D00018?

75N92019D00018 was awarded to Trustees Of Indiana University by National Heart Lung and Blood Institute (National Institutes of Health) on December 17, 2018.

How much is contract 75N92019D00018 worth?

Orders under 75N92019D00018 have obligated $6,975,731. 75N92019D00018's own ceiling is $8,000,000. A single order can be worth up to $8,000,000.

How many orders have been placed under contract 75N92019D00018?

10 orders have been placed under 75N92019D00018, the latest on June 16, 2025.

Who can order from contract 75N92019D00018?

75N92019D00018 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N92019D00018 competed?

The extent of competition for 75N92019D00018 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login